ADVANZ PHARMA Corp. (“ADVANZ PHARMA” or “the Company”), today announced it has successfully completed the Company’s global rebranding following shareholder approval of its name change last week from Concordia International Corp. to ADVANZ PHARMA Corp.
“This is an exciting period for ADVANZ PHARMA and all our employees across the globe,” said Graeme Duncan, Chief Executive Officer of ADVANZ PHARMA. “This new corporate identity, and the accompanying rebranding, will help define ADVANZ PHARMA as a global pharmaceutical company that is determined to help innovate, shape and grow the specialty off-patent sector. We will aim to go beyond what we have achieved in the past and current industry standards, as we look to capitalise on this new start.”
ADVANZ PHARMA represents a refocussed and redefined direction that will build on the Company’s current capabilities and global footprint across more than 90 countries so that it can meet the increasingly complex needs of global healthcare systems.
“This name change signifies a commitment to a refreshed vision and global strategy that offers true value to our customers, partners and stakeholders,” Mr Duncan added.
In addition to ensuring the continued supply of the Company’s extensive portfolio of high quality, established medicines, so that patients continue to get the medicines they need, ADVANZ PHARMA will focus on expanding its global presence in order to provide a platform for future growth.
Mr Duncan concluded: “Alongside our refocused corporate strategy, new leadership group and capital structure, ADVANZ PHARMA opens a new chapter in the Company’s history. With our strong financial position, highly supportive shareholder base and impressive heritage within the sector, we believe we are in a good position to become the most idea-generative company in the specialty, off-patent industry. We are looking to utilise these expertise to expand our already extensive portfolio through both pipeline development and the acquisition of companies and standalone medicines.”
Visit www.advanzpharma.com to explore the new website and learn more about ADVANZ PHARMA.